Trial Profile
Study of ipilimumab for the treatment of advanced melanoma in kidney transplant in French patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2018
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 23 Aug 2018 New trial record
- 14 Aug 2018 Results published in the American Journal of Transplantation